TPG Capital buys blood-screening system maker for $1.97 billion

July 5, 2011 by MassDevice staff

TPG Capital affiliate IVD Holdings Inc. entered into a definitive agreement to acquire all outstanding shares of Immucor Inc.'s (NSDQ:BLUD) common stock in a deal that's valued at $1.97 billion.

Immucor shareholders will get $27.00 in cash for each share of stock, about 30 percent higher than the stock's trading price prior to the announcement.

Immucor stock promptly jumped more than 30 percent to $27 per share when the information was released today, inching closer to the stock's 52-week high of $27.18.

Permalink